genavens
infect
occur
rare
person
aid
patient
present
case
alway
occur
immunocompromis
person
date
case
dissemin
infect
report
solidorgan
kidney
transplant
recipi
diagnosi
made
molecular
identifi
cation
isol
blood
marrow
cultur
patient
die
complic
genavens
infect
genavens
fastidi
organ
infect
caus
diffi
cult
diagnos
frequenc
probabl
underestim
may
chang
increas
use
direct
molecular
biolog
method
optim
treatment
genavens
infect
establish
experi
genavens
infect
aid
patient
nontubercul
mycobacteria
infect
solidorgan
transplant
recipi
suggest
least
antimicrobi
drug
use
prolong
period
possibl
immunosuppress
drug
concurr
reduc
outcom
nontubercul
mycobacteria
infect
transplant
patient
highli
variabl
satisfactori
present
patient
treat
quintupl
antimicrobialdrug
therapi
reduc
immunosuppress
therapi
case
dissemin
infect
due
genavens
heart
transplant
recipi
diagnos
earli
univers
rrna
gene
sequenc
amplifi
cation
directli
intestin
biopsi
specimen
enabl
fast
diagnosi
appropri
manag
editor
bat
thought
one
import
reservoir
virus
nipah
viru
sever
acut
respiratori
syndrom
sar
coronaviru
ebola
viru
pathogen
becam
known
extens
survey
bat
follow
outbreak
fi
rst
step
investig
unidentifi
ed
pathogen
bat
help
forecast
potenti
threat
emerg
infecti
diseas
tri
isol
character
virus
persist
infect
bat
process
isol
novel
adenoviru
fruit
bat
japan
pteropu
dasymallu
yayeyama
ryukyu
fl
ying
fox
fruit
bat
japan
permiss
governor
okinawa
caught
adult
male
bat
speci
use
spleen
kidney
establish
primari
cell
cultur
passag
primari
adher
cell
deriv
spleen
cytopath
effect
cpe
appear
without
visibl
microb
indic
cell
cultur
contain
viru
viru
tent
name
ryukyu
viru
caus
appar
cpe
primari
kidney
cell
deriv
ryukyu
fl
ying
fox
establish
bat
kidney
cell
deriv
kidney
horsesho
bat
rhinolophu
ferrumequinum
transform
express
plasmid
dna
encod
larg
antigen
replic
origindefect
simian
viru
identifi
viru
appli
rapid
determin
viral
rna
rdv
system
version
howev
viral
nucleic
acid
sequenc
detect
rna
sampl
cell
detect
viral
dna
develop
system
rapid
determin
viral
dna
sequenc
rdvd
minor
modifi
cation
rdv
system
rna
virus
result
indic
fragment
homolog
gene
encod
precursor
termin
protein
ptp
adenovirus
rdvd
analysi
show
fragment
bp
ddbjemblgenbank
access
homolog
ptp
gene
anoth
fragment
ddbjembl
genbank
access
homolog
gene
encod
precursor
protein
vi
pvi
adenovirus
result
indic
must
belong
famili
adenovirida
confi
rm
isol
adenoviru
use
pcr
sequenc
perform
fi
rst
reaction
outer
primer
pair
polfout
polrout
nest
pcr
method
target
viral
dna
polymeras
gene
highli
degener
consensu
primer
describ
recent
fragment
bp
amplifi
ed
well
human
data
shown
sequenc
analysi
amplifi
ed
product
ddbjemblgenbank
access
show
homolog
tree
shrew
adenoviru
amino
acid
sequenc
ident
porcin
adenoviru
canin
adenoviru
human
virus
genu
mastadenoviru
less
homolog
virus
genus
siadenoviru
aviadenoviru
atadenoviru
addit
phylogen
tree
base
amino
acid
sequenc
indic
belong
famili
adenovirida
genu
mastadenoviru
figur
electron
microscopi
cell
indic
accumul
nucleu
size
capsid
nm
data
shown
restrict
endonucleas
analysi
genom
indic
genom
kbp
data
shown
featur
consist
adenoviru
number
rna
virus
isol
bat
isol
dna
viru
rare
isol
novel
adenoviru
seem
possibl
usag
primari
cell
origin
host
dna
virus
might
restrict
host
rang
rna
virus
requir
hostorigin
cell
growth
addit
success
dna
viru
isol
might
result
usag
adult
anim
latent
persist
infect
dna
virus
adenoviru
herpesviru
conclus
isol
novel
viru
fruit
bat
viru
isol
healthi
bat
suggest
viru
may
persist
infect
fruit
bat
although
pathogen
human
still
unknown
knowledg
use
epidemiolog
studi
infecti
diseas
emerg
bat
persist
infect
virus
might
isol
togeth
primari
pathogen
plan
establish
cell
line
bat
isol
virus
persist
infect
bat
editor
fluoroquinolon
fq
activ
streptococc
speci
eg
levofl
oxacin
moxifl
oxacin
recommend
numer
nation
health
author
intern
organ
treat
acut
exacerb
chronic
bronchiti
pneumonia
adult
howev
use
antimicrobi
drug
treat
communityacquir
infect
led
increas
fqresist
strain
bacteria
streptococcu
pneumonia
group
b
streptococci
gb
eg
agalactia
lead
caus
invas
infect
pneumonia
septicemia
mening
neonat
gb
also
associ
bacteremia
endocard
arthriti
respons
death
ill
nonpregn
women
underli
diseas
elderli
adult
describ
knowledg
fi
rst
gb
clinic
isol
franc
resist
fq
isol
patient
treat
levofl
oxacin
gb
strain
isol
predomin
bacterium
cultur
cfuml
purul
sputum
sampl
man
leukocyt
epitheli
cell
obtain
day
apart
patient
treat
week
levofl
oxacin
mgday
acut
exacerb
chronic
bronchiti
relev
respiratori
bacteri
pathogen
present
sampl
gb
capsular
serotyp
iv
strain
suspect
reduc
suscept
fq
inhibit
zone
observ
around
disk
contain
norfl
oxacin
pefl
oxacin
disk
reduc
diamet
observ
around
disk
contain
ciprofl
oxacin
levofl
oxacin
antibiogram
perform
accord
recommend
clinic
laboratori
standard
institut
mueller
hinton
agar
biorad
marn
la
coquett
franc
supplement
hors
blood
strain
suscept
antimicrobi
drug
usual
activ
gb
penicillin
erythromycin
clindamycin
tetracyclin
rifampicin
vancomycin
show
lowlevel
resist
aminoglycosid
mic
fq
tabl
indic
gb
highli
resist
pefl
oxacin
norfl
oxacin
mic
mgl
show
increas
mic
ciprofl
oxacin
sparfl
oxacin
levofl
oxacin
moxifl
oxacin
reduct
fq
mic
observ
reserpin
mgl
indic
resist
fq
caus
activ
effl
ux
pump
system
three
major
mutat
report
fq
resist
streptococci
codon
posit
gyra
parc
dna
sequenc
analysi
region
show
mutat
parc
ser
tyr
wildtyp
suscept
strain
mutat
detect
gyra
gene
fq
resist
streptococci
acquir
stepwis
process
extens
studi
pneumonia
firststep
mutant
confer
lowlevel
resist
gener
result
mutat
either
gyra
parc
also
letter
comment
recent
articl
well
letter
report
case
outbreak
origin
research
welcom
letter
comment
articl
contain
word
refer
like
publish
submit
within
week
origin
articl
public
letter
report
case
outbreak
origin
research
contain
word
refer
may
one
figur
tabl
divid
section
letter
contain
materi
previous
publish
includ
word
count
